Kinetic Alteration of Human Aldose Reductase by Mutagenesis of Cysteine Residues

  • J. Mark Petrash
  • Theresa Harter
  • Ivan Tarle
  • David Borhani
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 328)


Aldose reductase (ALR21: alditol:NADPH oxidoreductase: E.C. catalyzes the NADPH-linked reduction of aldoses to their corresponding alcohols or polyols, the first step of the polyol pathway. Enhanced flux of glucose through the polyol pathway and consequent biochemical imbalances are thought to be crucial to the onset and progression of many complications of diabetes mellitus including cataract, retinopathy, neuropathy and nephropathy (Kinoshita and Nishimura, 1988). In light of its rate-limiting position in the polyol pathway as well as its apparent metabolic dispensability (Yancey et al., 1990), strategies to control or prevent the onset of diabetic complications through inhibition of aldose reductase are being aggressively pursued. While a structurally-diverse array of aldose reductase inhibitors (ARI) have yielded impressive results in animal studies, their effectiveness in arresting or preventing diabetic neuropathy (Boulton et al., 1990) and retinopathy (Sorbinil Retinopathy Trial Research Group, 1990) in human trials has been less encouraging (Frank, 1990).


Cysteine Residue Aldose Reductase Polyol Pathway Aldose Reductase Inhibitor Aldose Reductase Activity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Bhatnagar, A., Liu, S., Das, B., Srivastava, S.K., 1989, Involvement of sulfhydryl residues in aldose reductase-inhibitor interaction. Mol. Pharmacol. 36, 825–830.PubMedGoogle Scholar
  2. Bohren, K.M., Page, J.L., Shankar, R., Henry, S.P., and Gabbay, K.H., 1992, Expression of human aldose and aldehyde reductases: Site-directed mutagenesis of a critical lysine 262. J. Biol Chem. 266, 24031–24037.Google Scholar
  3. Borhani, D.W., Harter, T.M., and Petrash, J.M., 1992, The crystal structure of the aldose reductase-NADPH binary complex. J. Biol Chem. (submitted).Google Scholar
  4. Boulton, A.J.M., Levin, S., and Comstock, J., 1990, A multicentre trial of the aldose-reductase inhibitor, tolrestat, in patients with symptomatic diabetic neuropathy. Diabetologia, 33: 431–437.PubMedCrossRefGoogle Scholar
  5. Bradford, M.M., 1976, A rapid and sensitive method for the quantitation of microgram quantities of protein using the principle of dye-binding. Anal. Biochem. 72, 248–254.PubMedCrossRefGoogle Scholar
  6. Carper, D.A., Old, S.E., Sato, S. and Kador, P.F., 1991, Characterization of recombinant human placenta and rat lens aldose reductase expressed in Escherichia coli. ARVO abstracts. Supplement to Invest. Ophthal. Vis. Sci., 1991, p. 975, J.B. Lippincott, Philadelphia.Google Scholar
  7. Cleland, W.W., 1979, Stastical analysis of enzyme kinetic data. Methods Enzymol. 63, 103–138.PubMedCrossRefGoogle Scholar
  8. Das, B. and Srivastava, S.K., 1985, Activation of aldose reductase from human tissue. Diabetes 34, 1145–1151.PubMedCrossRefGoogle Scholar
  9. Del Corso, A., Camici, M. and Mura, U., 1987, In vitro modification of bovine lens aldose reductase activity. Biochem. Biophys. Res. Commun. 148: 369–375.PubMedCrossRefGoogle Scholar
  10. Del Corso, A., Barsacchi, D., Camici, M., Garland, D., and Mura, U. 1989a, Bovine lens aldose reductase: Identification of two enzyme forms. Arch. Biochem. Biophys. 270: 604–610.PubMedCrossRefGoogle Scholar
  11. Del Corso, A., Barsacchi, D., Giannessi, M., Tozzi, M.G., Camici, M., and Mura, U., 1989b, Change in stereospecificity of bovine lens aldose reductase modified by oxidative stress. J. Biol Chem. 264, 17653–17655.PubMedGoogle Scholar
  12. Del Corso, A., Barsacchi, D., Giannessi, M., Tozzi, M.G., Camici, M., Houben, J.L., Zandomeneghi, M., and Mura, U., 1990, Bovine lens aldose reductase: Tight binding of the pyridine coenzyme. Arch. Biochem. Biophys. 283: 512–518.PubMedCrossRefGoogle Scholar
  13. Flynn, T.G., 1982, Aldehyde reductases: Monomeric NADPH-depencent oxidoreductases with multifunctional potential. Biochem. Pharmacol. 31, 2705–2712.PubMedCrossRefGoogle Scholar
  14. Frank, R.N., 1990, Aldose reductase inhibition: The chemical key to the control of diabetic retinopathy? (editorial) Arch. Ophthal. 108, 1229–1231.PubMedCrossRefGoogle Scholar
  15. Graham, A., Hedge, P.J., Powell, S.J., Riley, J., Brown, L., Gammack, A., Carey, F., and Markham, A.F., 1989, Nucleotide sequence of cDNA for human aldose reductase. Nucl. Acids Res. 17, 8368.PubMedCrossRefGoogle Scholar
  16. Grundmann, Ulrich, Bohn, H., Obermeier, R., and Amann, E., 1990, Cloning and prokaryotic expression of a biologically active human placental aldose reductase. DNA and Cell Biol. 9, 149–157.CrossRefGoogle Scholar
  17. Jones, T.A., 1978, A graphics model building and refinement system for macromolecules. J. Appl. Cryst. 11, 268–272.CrossRefGoogle Scholar
  18. Kador, P.F., Kinoshita, J.H., Tung, W.H., and Chylack, L.T., Jr., 1980, Differences in the susceptibility of various aldose reductases to inhibition. Invest. Ophthal. Vis. Sci. 19: 980–982PubMedGoogle Scholar
  19. Kinoshita, J.H. and Nishimura, C., 1988, The involvement of aldose reductase in diabetic complications. Diabetes/Metabolism Reviews, 4: 323–337.PubMedCrossRefGoogle Scholar
  20. Kubiseski, T.J., Hyndman, DJ., Morjana, N.A., Flynn, T.G., 1992, Studies on pig muscle aldose reductase: Kinetic mechanism and evidence for a slow conformational change upon coenzyme binding. J. Biol. Chem. 267, 6510–6517.PubMedGoogle Scholar
  21. Kunkel, T.A., Roberts, J.D. and Zakour, R.A., 1987, Rapid and efficient site-specific mutagenesis without phenotypic selection. Methods Enzymol. 154, 367–382.PubMedCrossRefGoogle Scholar
  22. Liu, S., Bhatnagar, A., Das, B., and Srivastava, S.K., 1989, Functional cysteinyl residues in human placental aldose reductase, Arch. Biochem. Biophys. 275: 112–121.PubMedCrossRefGoogle Scholar
  23. Morjana, N.A. and Flynn, T.G., 1989, Aldose reductase from psoas muscle: Purification, substrate specificity, immunological characterization, and effect of drugs and inhibitors, J. Biol. Chem. 264, 2906–2911.PubMedGoogle Scholar
  24. Mylari, B.L., Larson, E.R., Beyer, T.A., Zembrowski, W.J., Aldinger, C.E., Dee, M.F., Siegel, T.W., and Singleton, D.H., 1991, Novel, potent aldose reductase inhibitors: 3,4-dihydro-4-oxo-3-[[5-(trifluoromethyl)-2-benzothiazolyl]methyl]-1-phthalazine-acetic acid (Zopolrestat) and congeners, J. Med. Chem. 34, 108–122.PubMedCrossRefGoogle Scholar
  25. Nishimura, C., Matsuura, Y., Kokai, Y. Akera, T., Carper, D., Morjana, N., Lyons, C., and Flynn, T.G., 1990, Cloning and expression of human aldose reductase. J. Biol. Chem. 265, 9788–9792.Google Scholar
  26. Olins, P.O. and Rangwala, S.H., 1990, Vector for enhanced translation of foreign genes in Escherichia coli. Methods Enzymol. 185, 115–119.Google Scholar
  27. Petrash, J.M., Harter, T.M., Devine, C., Olins, P., Bhatnagar, A., Liu, S., and Srivastava, S.K., 1992, Involvement of cysteine residues in catalysis and inhibition of human aldose reductase: Site-directed mutagenesis of cys-80, -298 and -303. J. Biol. Chem. (submitted).Google Scholar
  28. Petrash, J.M. and Favello, A.D., 1989, Isolation and characterization of cDNA clones encoding aldose reductase. Curr. Eye Res. 8, 1021–1027.PubMedCrossRefGoogle Scholar
  29. Plapp, B.V., Ganzhorn, A.J., Gould, R.M., Green, D.W., Warth, J.T., and Kratzer, D.A., 1991, Catalysis by yeast alcohol dehydrogenase. Adv. Exp. Med. Biol. 284, 241–251.PubMedCrossRefGoogle Scholar
  30. Poulsom, R., 1987, Comparison of aldose reductase inhibitors in vitro: Effects of enzyme purification and substrate type. Biochem. Pharm. 36, 1577–1581.PubMedCrossRefGoogle Scholar
  31. Rondeau, J.-M., Tête-Favier, F., Podjarny, A., Reymann, J.-M., Barth, P., Biellmann, J.-F., and Moras, D., 1992, Novel NADPH-binding domain revealed by the crystal struture of aldose reductase. Nature 355: 469–472.PubMedCrossRefGoogle Scholar
  32. Schade, S.Z., Early, S.L., Williams, T.R., Kezdy, F.J., Heinrikson, R.L., Grimshaw, C.E. and Doughty, C.C., 1990, Sequence analysis of bovine lens aldose reductase. J. Biol. Chem. 265, 3628–3635.PubMedGoogle Scholar
  33. Sorbinil Retinopathy Trial Research Group, 1990, A randomized trial of sorbinil, an aldose reductase inhibitor, in diabetic retinopathy. Arch. Ophthalmol. 108, 1234–1244.CrossRefGoogle Scholar
  34. Srivastava, S.K., Ansari, N.H., Hair, G.A., Jaspan, J., Rao, M.B., and Das, B., 1986, Hyperglycemia-induced activation of human erythrocyte aldose reductase and alteration in kinetic properties. Biochim. Biophys. Acta 870: 302–311.PubMedCrossRefGoogle Scholar
  35. Sussman, J.L., Holbrook, S.R., Church, G.M., Kim, S.-H., 1977, A structure-factor least-squares refinement procedure for macromolecular structures using constrained and restrained parameters. Acta Cryst. A23, 800–804.Google Scholar
  36. Tronrud, D.E., Ten Eyck, L.F., Matthews, B.W., 1987, An efficient general-purpose least-squares refinement program for macromolecular structures. Acta Cryst. A43, 489–501.Google Scholar
  37. Vander Jagt, D.L., Robinson, B., Taylor, K.K., and Hunsaker, L. A., 1990, Aldose reductase from human skeletal and heart muscle: Interconvertible forms related by thiol-disulfide exchange. J. Biol. Chem. 265: 20982–20987.Google Scholar
  38. Vander Jagt, D.L., Robinson, B., Taylor, K.K., and L. Hunsaker, 1992, Reduction of trioses by NADPH-dependent aldo-keto reductases: Aldose reductase, methylglyoxal, and diabetic complications. J. Biol. Chem. 267, 4364–4369.Google Scholar
  39. Wilson, D.K., Bohren, K.M., Gabbay, K.H., and Quiocho, F.A., 1992, An unlikely sugar substrate site in the 1.65Å structure of the human aldose reductase holoenzyme implicated in diabetic complications. Science 257: 81–84.PubMedCrossRefGoogle Scholar
  40. Yancey, P.H., Haner, R.G., and Freudenberger, T.H., 1990, Effects of an aldose reductase inhibitor on organic osmotic effectors in rat renal medulla. Am. J. Physiol. 259, F733–F738.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1993

Authors and Affiliations

  • J. Mark Petrash
    • 1
  • Theresa Harter
    • 1
  • Ivan Tarle
    • 1
  • David Borhani
    • 2
  1. 1.Departments of Ophthalmology and Visual Sciences and of GeneticsWashington University School of MedicineSt. LouisUSA
  2. 2.BioCryst Pharmaceuticals, Inc.BirminghamUSA

Personalised recommendations